loader2
Partner With Us NRI

Company details

64.60
68.90
52.00
79.90
6M Return -3.04%
1Y Return 3.01%
Mkt Cap.(Cr) 687.08
Volume 518,900
Div Yield 0.00%
OI
-
OI Chg %
-
Volume 518,900

Financials

  • Profit and loss statement

  • Balance sheet

  • Quarterly Result

  • Ratio

Sales(Cr.)

Operating Profit(Cr.)

Profit after Tax(Cr.)

Equity

Reserves and Surplus

Debt

Sales

Operating Profit

Profit after tax

PE

Debt/Equity

P BV

INSIDER & INSTITUIONAL ACTIVITY

Equity Capital: 243.55 Cr FV: 1.00
Period MF Net Purchase / (sold) FII Net
LAST 1M 9,103.15 -5,546.07
LAST 3M 56,745.22 -45,563.96
LAST 6M 87,261.41 -32,885.07
LAST 12M 98,501.34 -1,177.03

Information

  • About Company
  • Company Info
  • Listing Info
0
74.99%
23.6504
8.43%
6.24%
Description
  • Incorporated to take over the business of Dandekar & Company, Camlin got its present name in 1988. Starting with stationery products, it has diversified into art materials and pharmaceuticals. Its products are marketed under the popular Camel and Camlin brands. Its stationery division has a wide range of products like fountain pen inks, rubber stamp inks, duplicating inks, adhesives, writing instruments and gift sets, fountain-pen nibs and ball-point pens, erasers, stamp pads, scales, carbon paper, etc. The art material division supplies water colours, oil colours, poster colours, drawing inks, crayons, oil pastels, fabric colours, painting brushes, canvas, wooden and mechanical pencils, lead, markers; mathematical, engineering and biological instruments, etc. Bulk drugs like diloxanide fuorate, mebendazole, diazepam, etc, as well as a wide range of formulations (used in treating asthma, skin diseases, rheumatism, etc) are manufactured by the pharmaceutical division. Camlin started commercial production of high polymer lead in Mar.`90, in technical collaboration with Pilot Corporation, Japan, and has become one of the few companies in the world manufacturing the product. The company`s products are exported to east and west Asia, Europe, Africa, Australia, etc. Camlin has entered into a marketing alliance with Colart Fine Art and Graphics, UK, to market its Winsor & Newton premium range of colour products. Besides expanding its present manufacturing capacities, the company has also set up a plant to manufacture industrial grade synthetic adhesives, which commenced commercial production in Mar.`96. The plant for manufacturing bulk drugs/chemicals, commenced commercial production in 1995-96. Camlin International became a wholly-owned subsidiary of the company. During 1998-99, the company has raised a sum of Rs.750 lacs from IDBI through Private Placement of 16.5% Non Convertible Secured Redeemable Debentures for financing capital expenditure & long term working capital.The Erstwhile Stationery & Art Material Divisions have been merged into Consumer Products Division w.e.f. 1st April, 1999. The company undertook major expansion in production of anti-oxidant range of products.

Read More

Registered Address

48/2 Hilton House, Central Road MIDC Andheri (E), Mumbai, Maharashtra, 400093

Tel : 91-022-66557000
Email : investorrelations:kokuyocamlin.co
Website : http://www.kokuyocamlin.com

Registrar

Sharepro Services India P Ltd

AGM Date (Month) : Aug
Face Value Equity Shares : 1
Market Lot Equity Shares : 1
BSE Code : 523207
NSE Code : KOKUYOCMLN
Book Closure Date (Month) : Aug
BSE Group : B
ISIN : INE760A01029

Thank you for subscribing to Equity/ Equity Research/MF/FnO Newsletter. You will hear from us shortly.

for your vote

CLOSE